Here is how American Healthcare REIT (AHR) and Alerus (ALRS) have performed compared to their sector so far this year.
Smart money is piling into data centers and senior housing. One top activist REIT investor is making contrarian bets. INVH and NHI could be overlooked beneficiaries.
AI-driven capex and senior housing demand are the dominant growth trends shaping my current buy list. Despite a resurgence in inflation and soaring interest rates, stocks remain resilient, fueled by robust AI infrastructure spending. I am allocating fresh capital to three stocks and three ETFs, targeting dividend growth and AI exposure.
American Healthcare REIT (AHR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Here is how American Healthcare REIT (AHR) and Alerus (ALRS) have performed compared to their sector so far this year.
American Healthcare REIT is positioned to benefit from a multi-year supply-demand imbalance in senior housing, supporting robust occupancy and rent growth. AHR's double-digit NFFO and SPNOI growth, combined with a healthy acquisition pipeline and declining leverage, underpin expectations for mid-teens total returns. Trading at ~24x 2026 NFFO, AHR is a value play among senior housing REITs, with a well-covered 2% dividend yield and strong organic and external growth prospects.
Jefferies, an investment banking and capital management firm, has updated its ‘Franchise Picks' list, which features the company's highest-conviction ‘Buy' rated stocks.
American Healthcare REIT NYSE: AHR raised its 2026 outlook after reporting another quarter of double-digit same-store net operating income growth, supported by strength in its Trilogy integrated senior health campus business and senior housing operating portfolio.
American Healthcare REIT, Inc. (AHR) Q1 2026 Earnings Call Transcript
Here is how American Healthcare REIT (AHR) and Bank of Nova Scotia (BNS) have performed compared to their sector so far this year.
Algert Global LLC increased its position in shares of American Healthcare REIT, Inc. (NYSE: AHR) by 277.4% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 406,897 shares of the company's stock after purchasing an additional 299,075 shares during
American Healthcare REIT is upgraded to Buy, driven by robust portfolio growth, favorable macro trends, and strong FFO/NOI performance. AHR's diversified US/UK portfolio, low leverage (D/E 0.50), and expanding development pipeline position it well versus peers. Despite weaker EBITDA margins and modest dividend yield (1.9%), AHR's price forecasts and analyst consensus support upside.